Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.75 HKD | +0.69% | +9.96% | +6.36% |
Apr. 16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
Apr. 10 | Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.36% | 8.61B | |
+16.62% | 70.36B | |
+2.99% | 25.18B | |
+6.46% | 8.14B | |
-21.01% | 7.83B | |
-0.61% | 4.56B | |
+17.12% | 4.32B | |
-0.14% | 4.06B | |
-3.30% | 3.87B | |
+21.70% | 3.61B |
- Stock Market
- Equities
- 1099 Stock
- News Sinopharm Group Co. Ltd.
- Sinopharm : Seeks Emergency-Use Approval in Brazil for COVID-19 Vaccine